Skip to content
  • Careers
  • Contact
Pyxis Oncology Logo
  • About
    • Overview
    • Leadership
    • Partners
  • Our Approach
    • ADC Landscape
    • I/O Landscape
  • Portfolio
    • A Novel Pipeline
    • ADCs
    • Our Target Catalog
  • Investors
    • News releases
    • Events & presentations
    • Corporate governance
      • Governance Overview
      • Board of Directors
      • Management Team
      • Committee composition
    • Financial Information
      • SEC filings
    • Stock Information
      • Stock quote & chart
    • SHAREHOLDER SERVICES
      • Investor FAQs
      • Email alerts
      • RSS feeds
  • Media Coverage
Pyxis Oncology Logo
  • About
    • Overview
    • Leadership
    • Partners
  • Our Approach
    • ADC Landscape
    • I/O Landscape
  • Portfolio
    • A Novel Pipeline
    • ADCs
    • Our Target Catalog
  • Investors
    • News releases
    • Events & presentations
    • Corporate governance
      • Governance Overview
      • Board of Directors
      • Management Team
      • Committee composition
    • Financial Information
      • SEC filings
    • Stock Information
      • Stock quote & chart
    • SHAREHOLDER SERVICES
      • Investor FAQs
      • Email alerts
      • RSS feeds
  • Media Coverage
  • Careers
  • Contact

Media Coverage

May 19, 2021

Exploring the Tumor Microenvironment in Cancer Treatment

May 3, 2021

UChicago spinout Pyxis secures $152 million Series B, signs licensing agreement with Pfizer

April 27, 2021

ViewPoints Interview: Pyxis Oncology’s Dr. Lara S. Sullivan and Dr. Ronald Herbst Share Insights on the Importance of Series B Funding to Advance their Portfolio

April 27, 2021

Pyxis debuts next-gen cancer ADCs from under Pfizer’s wing

April 27, 2021

Other news to note for April 27, 2021

April 27, 2021

Pyxis unveils ambitions on ADCs

March 31, 2021

Money on the Move: March 24-30

March 31, 2021

Pyxis follows Pfizer alliance with $152m fundraising for cancer pipeline

March 31, 2021

Pyxis Oncology closes $152M Series B

March 31, 2021

Pyxis Oncology Raises $152M Series B Round

« Previous 1 2 3 4 Next »

35 Cambridgepark Drive
Suite 100-R
Cambridge, MA 02140
(617) 453-3596 | info@pyxisoncology.com

Pyxis Oncology
Twitter Linkedin-in
  • Copyright © 2022 Pyxis Oncology
  • Privacy Policy
  • Accessibility